Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis

Nianyi Li, Pei Lin, Zhuang Zuo, M. James You, Wen Shuai, Robert Orlowski, Elisabet E. Manasanch, Shaoying Li, Jie Xu, Sofia Garces, Fatima Zahra Jelloul, Zhenya Tang, Wei Wang, L. Jeffrey Medeiros, C. Cameron Yin

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis'. Together they form a unique fingerprint.

Medicine & Life Sciences